Delivery Order SPE2DR25D3301-SPE2DR26F18ET
Award Date 11/18/25
Potential Completion Date 12/10/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,519.62 for 120 tablets of Lynparza 100 mg on July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside transaction executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be performed...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Lynparza 150 mg tablets (120-count units) with a contract ceiling value of $11,136.63. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,543.70 for 60 tablets of Lynparza 100 mg on July 30, 2025, with an ultimate completion date of August 20, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and is being fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location. The contract represents a continuation of pharmaceutical supply services under AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a $10,567.60 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Lynparza 150 mg tablets (120 count). The contract, which is non-set-aside and competitively awarded, is scheduled for completion by November 6, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Lynparza 150 mg tablets (120-count units) with a firm fixed price ceiling value of $21,135.20 and ultimate completion date of September 10, 2025. This delivery order represents a non-competitive award and is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Lynparza 150 mg tablets (120 count units) with a ceiling value of $42,270.40. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procurement procedures. The order is scheduled for ultimate completion by September 15, 2025, and will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania. As a child...
- The Defense Logistics Agency awarded a $11,064.68 delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of 60 tablets of LYNPARZA 150 mg, with completion scheduled for November 10, 2025. This competitively awarded, non-set-aside contract employs firm fixed-price terms and is being performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with...
- This delivery order, awarded May 1, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides 120 tablets of Lynparza 150 mg under a firm fixed price contract valued at $10,567.60, with completion scheduled for May 22, 2025. The award carries no set-aside designation and represents a competitively awarded delivery order for a brand-name oncology medication. This order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $21,135.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 120 tablets of LYNPARZA 150 mg on August 18, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled from AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of LYNPARZA 100 mg tablets (120-count units) with a ceiling value of $10,519.62. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. LYNPARZA is an oncology pharmaceutical used in cancer treatment,...